![]() |
市場調查報告書
商品編碼
2046424
婦科手術椅和手術台市場-全球產業規模、佔有率、趨勢、機會和預測:按產品、應用、最終用途、地區和競爭格局分類,2021-2031年Gynecological Chairs and Tables Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End Use, By Region & Competition, 2021-2031F |
||||||
全球婦科椅和桌子市場預計將從 2025 年的 8.3711 億美元成長到 2031 年的 12.5065 億美元,複合年成長率為 6.92%。
該市場涵蓋專為確保醫護人員符合人體工學的姿勢以及在骨盆檢查、小型手術和外科手術中為患者提供舒適體驗而設計的專用醫療家具。推動這一市場成長的主要因素是子宮頸癌和子宮肌瘤等婦科疾病發病率的上升,以及人們對預防性女性健康篩檢日益成長的關注,這反過來又需要加強臨床基礎設施建設。例如,美國癌症協會估計,到2025年,美國將新增13,360例浸潤性子宮頸癌病例,凸顯了診斷能力對於應對此疾病負擔的迫切需求。然而,市場成長的一個主要限制因素是高度自動化的婦科設備需要大量的資本投資,尤其是在醫療預算有限的發展中地區。這一經濟障礙迫使許多低收入地區的醫療機構繼續使用過時或手動設備,導致現代解決方案的普及速度緩慢,並限制了這些地區市場的收入潛力。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 8.3711億美元 |
| 市場規模:2031年 | 1,250,650,000 美元 |
| 複合年成長率:2026-2031年 | 6.92% |
| 成長最快的細分市場 | 骨盆腔手術 |
| 最大的市場 | 北美洲 |
婦科疾病和慢性病盛行率的上升是推動市場擴張的主要動力,也因此催生了對符合人體工學、先進的醫療家具的需求,這些家具對於診斷和手術至關重要。隨著子宮肌瘤、子宮內膜異位症和骨盆底功能障礙等疾病的日益普遍,醫療機構正在升級設備,以應對不斷成長的手術量並取得更好的臨床效果。 Hologic公司等企業也印證了這一趨勢,該公司2025會計年度第一季婦科手術相關銷售額成長至1.663億美元,這主要得益於強勁的國際需求。此外,政府支持和優惠的報銷政策改善了預防性醫療保健基礎設施的可近性,也加速了這些專用座椅和檢查台的普及。世界衛生組織和各國政府正大力投資根除子宮頸癌等疾病的策略,這需要廣泛部署配備專用檢查台的篩檢中心。例如,全球疫苗免疫聯盟(Gavi)計畫在2026年至2030年間,將符合人類乳突病毒(HPV)疫苗資格的女孩人數增加1.2億以上,以配合擴大篩檢範圍。這項由公共部門主導的計劃正得到私人投資的推動。根據矽谷銀行的報告顯示,到2024年,女性健康領域的資金將達到創紀錄的26億美元,為醫療設施現代化提供了所需的資金。
先進婦科設備所需的巨額資本投入對市場成長構成重大障礙,尤其是在醫療預算有限的發展中地區。儘管臨床上對符合人體工學設計的自動化家有明確的需求,但其成本往往超出了許多公立醫療機構的購買力。這種經濟負擔常常迫使低收入地區的醫院繼續使用過時或手動設備,而不是升級到最新型號,從而阻礙了先進技術解決方案的採用,並造成了創新與市場滲透之間的差距。這種經濟壓力導致對非關鍵基礎設施的投資被推遲;據美國醫院協會 (AHA) 稱,由於營運成本上升,94% 的醫療機構管理者預計到 2025 年將推遲設備升級。面臨預算限制的醫療機構優先考慮眼前的耗材,而不是長期的家具投資。因此,製造商在成本敏感地區的銷售下降,嚴重限制了其在全球市場的潛在收入。
為因應全球肥胖症的流行,製造商正在調整產品線,推出更大容量的型號,以滿足肥胖患者的需求。醫療機構對婦科檢查床的需求日益成長,要求配備加強框架、寬大坐墊和高承重能力,以確保患者在檢查過程中的安全和尊嚴。這一趨勢將堅固的結構設計與低矮的高度相結合,方便患者上下床,從而降低患者和醫護人員在轉移過程中受傷的風險。根據《2025年世界肥胖地圖集》,預計到2030年,全球將有11.3億成年人肥胖,凸顯了改進臨床家具以滿足更廣泛患者群體需求的緊迫性。同時,採用永續和環保的生產方式正成為關鍵的競爭優勢。供應商正在透過使用可回收金屬和減少揮發性有機化合物(VOC)排放來實踐循環經濟原則,以滿足醫院採購中的環保要求。這種業務運營的轉變也體現在像史賽克這樣的領先公司的戰略計劃中,該公司計劃到 2030 年實現其工廠的碳中和,到 2027 年實現 100% 使用可再生能源,這表明整個行業正在加強減少醫療設備生產對環境的影響。
The global market for gynecological chairs and tables is projected to expand from USD 837.11 Million in 2025 to USD 1250.65 Million by 2031, demonstrating a compound annual growth rate (CAGR) of 6.92%. This market encompasses specialized medical furniture engineered to provide ergonomic positioning for clinicians and comfort for patients during pelvic examinations, minor procedures, and surgeries. Growth is primarily driven by the increasing incidence of gynecological conditions like cervical cancer and fibroids, alongside a greater focus on preventive women's health screenings, which mandates enhanced clinical infrastructure. For example, the American Cancer Society estimated 13,360 new invasive cervical cancer cases in the US in 2025, highlighting the critical need for diagnostic capabilities to manage this disease burden. However, a key impediment to market growth is the substantial capital expenditure required for advanced, automated gynecological units, especially in developing regions with constrained healthcare budgets. This financial hurdle compels many facilities in lower-income areas to continue using older or manual equipment, thus slowing the adoption of modern solutions and limiting market revenue potential in these geographies.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 837.11 Million |
| Market Size 2031 | USD 1250.65 Million |
| CAGR 2026-2031 | 6.92% |
| Fastest Growing Segment | Pelvic Surgery |
| Largest Market | North America |
Market Driver
The growing prevalence of gynecological disorders and chronic conditions serves as a primary catalyst for market expansion, creating a demand for advanced ergonomic furniture essential for diagnostic and surgical procedures. As conditions such as uterine fibroids, endometriosis, and pelvic floor disorders become more widespread, healthcare providers are enhancing their equipment to manage increased procedural volumes and achieve better clinical results, a trend underscored by companies like Hologic, Inc., whose gynecological surgical revenue increased to $166.3 million in Q1 Fiscal 2025 due to robust international demand. Furthermore, supportive government initiatives and advantageous reimbursement policies are accelerating the adoption of these specialized chairs and tables by improving access to preventive care infrastructure. Global health bodies and national governments are significantly investing in strategies to eliminate diseases like cervical cancer, necessitating the broad deployment of screening units equipped with specialized examination tables. Gavi, the Vaccine Alliance, for instance, plans to vaccinate over 120 million additional girls with HPV vaccines between 2026 and 2030, complementing expanded screening mandates. This public sector drive is bolstered by private investment, with women's health funding reaching a record $2.6 billion in 2024, as reported by Silicon Valley Bank, providing the necessary capital for healthcare facilities to modernize.
Market Challenge
The substantial capital investment required for advanced gynecological units poses a significant obstacle to market growth, especially in developing regions constrained by limited healthcare budgets. Despite the clear clinical need for ergonomic and automated furniture, the cost often surpasses the purchasing capacity of many public health facilities. This financial strain frequently compels hospitals in low-income areas to prolong the use of outdated or manual equipment instead of upgrading to modern models, thus impeding the adoption of advanced technological solutions and creating a disparity between innovation and market penetration. This economic pressure leads to deferrals in capital expenditure for non-critical infrastructure, with 94 percent of healthcare administrators in 2025 expecting to delay equipment upgrades due to rising operational costs, according to the American Hospital Association. Faced with budget constraints, facilities prioritize immediate consumables over long-term furniture investments, which ultimately reduces sales volumes for manufacturers in cost-sensitive areas and significantly restricts the global market's revenue potential.
Market Trends
Manufacturers are adapting their product offerings to include high-capacity bariatric-compliant models in response to the rising global obesity epidemic. Healthcare facilities are increasingly seeking gynecological tables featuring reinforced frames, broader upholstery, and higher weight capacities to ensure patient safety and dignity during examinations. This trend merges sturdy structural design with accessible low-entry heights, reducing the risk of transfer-related injuries for both patients and clinicians. The World Obesity Federation's 'World Obesity Atlas 2025' projects that 1.13 billion adults will be living with obesity by 2030, underscoring the necessity for upgraded clinical furniture to accommodate larger patient populations. Simultaneously, the adoption of sustainable and eco-friendly manufacturing practices is becoming a crucial competitive advantage. Suppliers are embracing circular economy principles by using recyclable metals and minimizing volatile organic compound emissions to align with hospital procurement environmental requirements. This operational shift is reflected in the strategic plans of major industry players like Stryker, which aims for carbon neutrality in its facilities by 2030 and 100% renewable electricity by 2027, indicating a wider industry dedication to lessening the environmental impact of medical equipment production.
Report Scope
In this report, the Global Gynecological Chairs and Tables Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Gynecological Chairs and Tables Market.
Global Gynecological Chairs and Tables Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: